Intellia Therapeutics, Inc. (NTLA)
13.63
-2.24
(-14.11%)
USD |
NASDAQ |
Apr 24, 16:00
16.26
+2.63
(+19.30%)
Pre-Market: 20:00
Intellia Therapeutics Market Cap : 1.610B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.854B |
| Regeneron Pharmaceuticals, Inc. | 79.46B |
| KalVista Pharmaceuticals, Inc. | 1.005B |
| Novavax, Inc. | 1.339B |
| Beam Therapeutics, Inc. | 2.761B |
Market Cap Related Metrics
| PS Ratio | 21.82 |
| Price to Book Value | 2.398 |
| Price | 13.63 |
| Earnings Yield | -28.07% |